Saturday , May 28 2022

California Research Group publishes promising results for a universal peptide-based cancer vaccine


SANTA CLARA, CA., 7. November 2018 / PRNewswire / – A team of Drs. Rath Research Institute in California has developed a cancer vaccine
which reduces tumor growth. This peptide-based vaccine targets specific enzymes called metalloproteinases (MMPs) which are responsible for tumor growth
The formation of metastases and blood vessels in tumors (angiogenesis) is responsible. Dr. Rath research team showed that tested mice vaccinated with peptides, specific
Sequences of MMP-2 and MMP-9 and then infected with melanoma cells, an average reduction of the tumor by approximately 76% compared with unvaccinated
Animals from the control group. Remarkably, some vaccinated animals did not develop cancer at all.

California research team results from peptide-based universal cancer vaccine

The study was published in October 2018 in the Online Journal of Cellular Medicine and Natural Health.

Source link